prochlorperazine IV
Selected indexed studies
- 2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies. (Headache, 2026) [PMID:41321235]
- Randomized study of IV prochlorperazine plus diphenhydramine vs IV hydromorphone for migraine. (Neurology, 2017) [PMID:29046364]
- A randomized study of IV prochlorperazine plus diphenhydramine versus IV hydromorphone for migraine-associated symptoms: A post hoc analysis. (Headache, 2021) [PMID:34363617]
_Worker-drafted node — pending editorial review._
Connections
prochlorperazine IV is a side effect of
Sources
- The efficacy and safety of metoclopramide in relieving acute migraine attacks compared with other anti-migraine drugs: a systematic review and network meta-analysis of randomized controlled trials. (2023) pubmed
- 2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies. (2026) pubmed
- Randomized study of IV prochlorperazine plus diphenhydramine vs IV hydromorphone for migraine. (2017) pubmed
- A randomized study of IV prochlorperazine plus diphenhydramine versus IV hydromorphone for migraine-associated symptoms: A post hoc analysis. (2021) pubmed
- IV prochlorperazine + diphenhydramine improved migraine pain relief more than IV hydromorphone in the ED. (2018) pubmed
- Droperidol vs. prochlorperazine for benign headaches in the emergency department. (2001) pubmed
- IV Amisulpride (Barhemsys) for postoperative nausea and vomiting. (2020) pubmed
- Emergency Department Use of Intravenous Prochlorperazine for Acute Migraine. (2018) pubmed
- Inhaled drug therapy development for the treatment of migraine. (2016) pubmed
- Buccally absorbed vs intravenous prochlorperazine for treatment of migraines headaches. (2019) pubmed